Iron team of investigators were scientists from the Cleveland Clinic Foundation, the Hopital La Pitie Salpetriere in France, University of California at Los Angeles, Columbia Presbyterian Medical Center in New York, Stanford University School of Medicine in California, Skejby University Hospital Denmark, German Heart Centre in Germany and Novartis in East Hanover, and Basel, Switzerland.

Long-term complications reduced cardiac transplant complicationsContact: Jordan Reese, Temple University 215-707-4983 Porter NovelliTemple University study reported in the New England Journal of MedicinePhiladelphia, Pennsylvania – Treatment with the new immunosuppressant everolimus is significantly more effective in reducing the severity and frequency of severe complications in cardiac transplant as the current therapy, according to a study in the 28th August The New England Journal of Medicine.Financial for the research did partly from aid from the Howard Hughes Medical Institute and of the nation Institute of Health.